Table 3(b).
Term | HR | HR 95% lower | HR 95% upper | p Value |
---|---|---|---|---|
Former smoking versus never smoker | 0.862 | 0.532 | 1.397 | 0.546 |
Current smoking versus never smoker | 1.140 | 0.677 | 1.918 | 0.623 |
Age at diagnosis | 0.999 | 0.980 | 1.017 | 0.879 |
Male versus female | 0.873 | 0.520 | 1.466 | 0.607 |
NSAID use | 1.091 | 0.676 | 1.759 | 0.722 |
Aspirin use | 2.104 | 1.337 | 3.311 | 0.001 |
PPI use | 2.012 | 1.340 | 3.023 | 0.001 |
Statin use | 1.022 | 0.626 | 1.668 | 0.931 |
Histamine-2 antagonist use | 0.470 | 0.111 | 1.995 | 0.306 |
Antipsychotic medication use | 1.215 | 0.774 | 1.907 | 0.397 |
Budesonide treatment | 1.856 | 1.157 | 2.977 | 0.010 |
Prednisone treatment | 1.445 | 0.631 | 3.311 | 0.384 |
Imodium treatment | 0.842 | 0.526 | 1.347 | 0.473 |
Mesalamine treatment | 0.398 | 0.191 | 0.829 | 0.014 |
Bismuth treatment | 1.025 | 0.657 | 1.599 | 0.913 |
Other treatment options | 1.270 | 0.673 | 2.399 | 0.461 |
Presence of symptoms | 0.717 | 0.289 | 1.777 | 0.473 |
CC versus LC | 0.701 | 0.468 | 1.049 | 0.084 |
Index biopsies with mixed MC findings were not included in the analysis, and only assessments with a definitive diagnosis of CC or LC were considered as the index diagnosis. Mixed MC findings were only included if found after an index biopsy.
CC, collagenous colitis; HR, hazard ratio; LC, lymphocytic colitis; NSAID, nonsteroidal anti-inflammatory drugs; PPI, proton-pump inhibitor.